abstract |
The invention provides a pharmaceutical composition for treating HTLV-1 (Human T-lymphotropic Virus Type 1) related myelopathy, which comprises a group selected from the group consisting of EZH1 inhibitor, EZH2 inhibitor and EZH1 / 2 dual inhibitor Group inhibitors as active ingredients. The present invention provides a pharmaceutical composition for treating HTLV-1 related myelopathy, which comprises 1,3-benzobis Uh (1,3-benzodioxole) derivatives or their pharmaceutically acceptable salts. |